AstraZeneca agrees to lower drug prices for Medicaid under Trump administration deal

AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration that avoided its threats of steep tariffs. President Donald Trump made the announcement in the Oval Office with AstraZeneca CEO Pascal Soriot, who said that during tough negotiations to reach a deal, Trump and his team of officials had “really kept me up at night.”